Riluzole treatment for SCA7 nerve balance problems
Treatments studied
Part of Brain & nervous system clinical trials.
This trial studies whether riluzole can help people with spinocerebellar ataxia type 7 (SCA7), a genetic condition that affects balance and coordination. It may help slow symptoms or improve daily function, and you’d be closely monitored for side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed genetic test showing SCA7.
- You should not have abnormal heart rhythm problems (cardiac arrhythmias).
- You should not have significant blood or blood-forming problems (hematologic diseases).
- Your liver tests must not be more than 1.5 times above normal (based on ALT, AST, and bilirubin).
- If you can become pregnant, you must agree to use contraception during the study.
- You cannot be breastfeeding during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial provides access to an unapproved medication called troriluzole for people with spinocerebellar ataxia (SCA), a rare condition that affects coordination and movement. The drug may help slow progression, and this program offers a chance to receive it before it's widely available.
This study follows people with certain types of spinocerebellar ataxia (a group of conditions that cause progressive movement problems) to understand how the disease changes over time and how genes might influence it. It may help researchers learn more about these conditions and support future treatments.
This study tests whether a non-invasive brain stimulation treatment (called cerebellar transcranial magnetic stimulation) can help improve balance and coordination in people with spinocerebellar ataxia. It may offer a new way to ease symptoms without surgery.
This trial tests if fampridine, a medication, can improve walking and coordination in people with SCA27B, a specific inherited ataxia. It compares fampridine to a placebo over a period of time.
This trial tests an experimental stem cell treatment for people with SCA3, a genetic condition that affects balance and coordination. The goal is to see if the treatment can help improve or slow down these symptoms.
This study tests a new kind of deep brain stimulation that adjusts automatically to improve balance and coordination in adults with SCA6, a genetic form of ataxia. It may help patients who can still walk but have moderate to severe symptoms.
Hear when a new SCA7 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.